InChI=1S/C19H22N2.ClH/c1- 16- 7- 9- 17(10- 8- 16) 18(19- 6- 2- 3- 12- 20- 19) 11- 15- 21- 13- 4- 5- 14- 21;/h2- 3,6- 12H,4- 5,13- 15H2,1H3;1H/b18- 11+; |
WYUYEJNGHIOFOC-NWBUNABESA-N |
Cl.Cc1ccc(cc1)C(=C/CN1CCCC1)\c1ccccn1 |
|
H1-receptor antagonist
H1-receptor antagonists are the drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine.
|
|
H1-receptor antagonist
H1-receptor antagonists are the drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine.
|
|
View more via ChEBI Ontology
2-[(1E)-1-(4-methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridine hydrochloride
|
1-[(2E)-3-(4-methylphenyl)-3-(pyridin-2-yl)prop-2-en-1-yl]pyrrolidinium chloride
|
IUPAC
|
triprolidine hydrochloride (anhydrous)
|
ChEBI
|
triprolidine hydrochloride anhydrous
|
ChemIDplus
|
triprolidine monohydrochloride (anh.)
|
ChEBI
|
triprolidine monohydrochloride (anhydrous)
|
ChEBI
|
triprolidine monohydrochloride anhydrous
|
ChEBI
|
3743215
|
Reaxys Registry Number
|
Reaxys
|
550-70-9
|
CAS Registry Number
|
ChemIDplus
|
|